Dougherty Michael Philip 4
4 · bioAffinity Technologies, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Dougherty Michael Philip
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-31+31,847→ 84,203 total
Footnotes (1)
- [F1]Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.